Repligen (RGEN) Market Capitalization (2010 - 2026)

Repligen (RGEN) has reported Market Capitalization for 17 consecutive years, with $7.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 10.04% year-over-year to $7.7 billion in Q2 2026; TTM through Jun 2026 was $7.7 billion, a 10.04% increase from a year earlier, with the FY2025 full-year figure at $9.2 billion, up 14.31% from the prior year.
• Market Capitalization was $7.7 billion for Q2 2026 at Repligen, up from $6.6 billion in the prior quarter.
• Over five years, Market Capitalization peaked at $10.4 billion in Q1 2022 and troughed at $6.6 billion in Q1 2026.
• A 5-year average of $8.6 billion and a median of $8.6 billion in 2023 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 35.8% in 2022 and climbed 14.31% in 2025, its largest moves.
• Over 5 years, Market Capitalization stood at $9.4 billion in 2022, then grew by 6.59% to $10.0 billion in 2023, then dropped by 19.48% to $8.1 billion in 2024, then advanced by 14.31% to $9.2 billion in 2025, then declined by 16.58% to $7.7 billion in 2026.
• The last three Market Capitalization figures came in at $7.7 billion (Q2 2026), $6.6 billion (Q1 2026), and $9.2 billion (Q4 2025), per Business Quant data.